BackIntegrated Proteins Limited Overview

Integrated Proteins Limited EBIT

Track Integrated Proteins Limited's EBIT ($7.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$739.00K
↓ 16.02% YoY

As of Sep 30, 2026

Annual EBIT (TTM)

$7.58M
↑ 56.99% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Integrated Proteins Limited (INTEGFD.BO) FAQ

The latest EBIT for INTEGFD.BO is $7.6M as of September 2026. That compares with $4.8M in the prior-year period — up 57.0% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside Integrated Proteins Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, INTEGFD.BO's EBIT moved from $4.8M to $7.6M — a 57.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Integrated Proteins Limited's operating scale or balance-sheet position.

Against its sector companies, INTEGFD.BO currently prints $7.6M for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Integrated Proteins Limited's growth, margins, and balance sheet.

A EBIT figure of $7.6M for INTEGFD.BO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting INTEGFD.BO's EBIT ($7.6M), review year-over-year change from $4.8M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.